Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/21659
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sze Ting | - |
dc.contributor.author | Burvenich, Ingrid J G | - |
dc.contributor.author | Scott, Andrew M | - |
dc.date | 2019-07-06 | - |
dc.date.accessioned | 2019-09-02T01:06:47Z | - |
dc.date.available | 2019-09-02T01:06:47Z | - |
dc.date.issued | 2019-09 | - |
dc.identifier.citation | Seminars in nuclear medicine 2019; 49(5): 357-368 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/21659 | - |
dc.description.abstract | Nuclear medicine techniques involving SPECT and PET are being increasingly used as a noninvasive tool for the detection, quantitation and therapy response monitoring of a myriad of disease processes through target visualization and kinetic modeling. The target selection requires a good understanding of the physiologic changes involved in the disease processes. The target selected can range from cellular proteins expressed in a particular organ, biochemical pathways in cells, or receptors on circulating blood cells. This can have a significant impact on therapeutic options for subsequent therapies, including radionuclide therapies in this evolving world of theranostic practices, which is outlined in this review. | - |
dc.language.iso | eng | - |
dc.title | Novel Target Selection for Nuclear Medicine Studies. | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Seminars in nuclear medicine | - |
dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Melbourne, Australia | en |
dc.identifier.affiliation | Faculty of Medicine, The University of Melbourne, Melbourne, Australia | en |
dc.identifier.affiliation | Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.doi | 10.1053/j.semnuclmed.2019.06.004 | - |
dc.identifier.orcid | 0000-0001-8641-456X | - |
dc.identifier.orcid | 0000-0002-6656-295X | - |
dc.identifier.pubmedid | 31470931 | - |
dc.type.austin | Journal Article | - |
dc.type.austin | Review | - |
local.name.researcher | Lee, Sze Ting | |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.